Literature DB >> 17595160

Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.

Jennifer L Newell1, Philip J Fay.   

Abstract

Thrombin activates factor VIII by proteolysis at three P1 residues: Arg372, Arg740, and Arg1689. Cleavage at Arg372 and Arg1689 are essential for procofactor activation; however cleavage at Arg740 has not been rigorously studied. To evaluate the role for cleavage at Arg740, we prepared and stably expressed two recombinant B-domainless factor VIII mutants, R740H and R740Q to slow and eliminate, respectively, cleavage at this site. Specific activity values for the variants were approximately 50 and 20%, respectively, that of wild-type factor VIII. Activation of factor VIII R740H by thrombin showed an approximately 40-fold reduction in the rate of A2 subunit generation, which reflected an approximately 20-fold reduction in cleavage rate at Arg372. Similarly, a approximately 40-fold rate reduction in cleavage at Arg1689 and consequent generation of the A3-C1-C2 subunit were observed. Rate values for A2 and A3-C1-C2 subunit generation were reduced by >700-fold and approximately 140-fold, respectively, in the R740Q variant. These results suggest that initial cleavage at Arg740 affects cleavage at both Arg372 and Arg1689 sites. Results obtained evaluating proteolysis of the factor VIII mutants by factor Xa revealed more modest rate reductions (<10-fold) in generating A2 and A3-C1-C2 subunits from either variant, suggesting that factor Xa-catalyzed activation of factor VIII was significantly less dependent upon prior cleavage at residue 740 than thrombin. Overall, these results support a model whereby cleavage of factor VIII by thrombin is an ordered pathway with cleavage at Arg740 facilitating cleavages at Arg372 and Arg1689, which result in procofactor activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595160     DOI: 10.1074/jbc.M703433200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  J Coagul Disord       Date:  2010-07-01

2.  P3-P3' residues flanking scissile bonds in factor VIII modulate rates of substrate cleavage and procofactor activation by thrombin.

Authors:  Jennifer L Newell-Caito; Amy E Griffiths; Philip J Fay
Journal:  Biochemistry       Date:  2012-04-10       Impact factor: 3.162

3.  In vivo efficacy of platelet-delivered, high specific activity factor VIII variants.

Authors:  Teshell K Greene; Cheng Wang; Jessica D Hirsch; Li Zhai; Jamie Gewirtz; Michael A Thornton; Hongzhi Z Miao; Steven W Pipe; Randal J Kaufman; Rodney M Camire; Valder R Arruda; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

4.  The role of P4-P3' residues flanking Arg336 in facilitating activated protein C-catalyzed cleavage and inactivation of factor VIIIa.

Authors:  Jennifer P DeAngelis; Fatbardha Varfaj; Hironao Wakabayashi; Philip J Fay
Journal:  Thromb Res       Date:  2011-04-05       Impact factor: 3.944

5.  Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.

Authors:  Divi Venkateswarlu
Journal:  BMC Struct Biol       Date:  2010-02-25

Review 6.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

7.  Acidic residues C-terminal to the A2 domain facilitate thrombin-catalyzed activation of factor VIII.

Authors:  Jennifer L Newell; Philip J Fay
Journal:  Biochemistry       Date:  2008-07-22       Impact factor: 3.162

8.  Cleavage at Arg-1689 influences heavy chain cleavages during thrombin-catalyzed activation of factor VIII.

Authors:  Jennifer L Newell; Philip J Fay
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

Review 9.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

10.  An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII.

Authors:  Behnaz Pezeshkpoor; Ursula Schreck; Arijit Biswas; Julia Driesen; Ann-Cristin Berkemeier; Anna Pavlova; Jens Müller; Johannes Oldenburg
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.